StockData
QIAGEN N.V. logo

QIAGEN N.V. (QGEN) stock

QGENNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 10/30
$49.75−0.06 (-0.12%)

Close on Nov 17, 2026Market cap $10.79BP/E 25.6Yield 0.50%

Qiagen total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Qiagen's total debt was $1.65B at Dec 31, 2025. For fiscal 2025 it was $1.65B, up 18.9% from the year before. Over ten years it grew 4.7% a year on average. The highest annual figure on record is $2.17B in fiscal 2018.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.65B+18.9%
FY2024Dec 31, 2024$1.39B-7.8%
FY2023Dec 31, 2023$1.51B-18.9%
FY2022Dec 31, 2022$1.86B-4.1%
FY2021Dec 31, 2021$1.94B+1.0%
FY2020Dec 31, 2020$1.92B+12.7%
FY2019Dec 31, 2019$1.71B-21.5%
FY2018Dec 31, 2018$2.17B+23.7%
FY2017Dec 31, 2017$1.76B+64.8%
FY2016Dec 31, 2016$1.07B+1.7%
FY2015Dec 31, 2015$1.05B-10.5%
FY2014Dec 31, 2014$1.17B+38.6%
FY2013Dec 31, 2013$845.48M-0.2%
FY2012Dec 31, 2012$846.99M+43.6%
FY2011Dec 31, 2011$589.95M-32.4%
FY2010Dec 31, 2010$873.01M-5.1%
FY2009Dec 31, 2009$920.00M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025$1.65B-14.8%
Q4 FY2024Dec 31, 2024$1.39B-27.6%
Q4 FY2023Dec 31, 2023$1.51B-11.5%
Q4 FY2022Dec 31, 2022$1.86B-14.4%
Q4 FY2021Dec 31, 2021$1.94B+10.4%
Q4 FY2020Dec 31, 2020$1.92B+80.2%
Q4 FY2019Dec 31, 2019$1.71B+62.7%
Q4 FY2018Dec 31, 2018$2.17B+85.5%
Q4 FY2017Dec 31, 2017$1.76B+108.0%
Q4 FY2016Dec 31, 2016$1.07B+26.0%
Q4 FY2015Dec 31, 2015$1.05B+77.8%
Q4 FY2014Dec 31, 2014$1.17B+34.3%
Q4 FY2013Dec 31, 2013$845.48M-8.1%
Q4 FY2012Dec 31, 2012$846.99M–
Q4 FY2011Dec 31, 2011$589.95M–
Q4 FY2010Dec 31, 2010$873.01M–
Q4 FY2009Dec 31, 2009$920.00M–

More Qiagen figures

See a number that looks wrong?